272 related articles for article (PubMed ID: 29804481)
21. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
[TBL] [Abstract][Full Text] [Related]
22. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.
Löscher W; Potschka H
J Pharmacol Exp Ther; 2002 Apr; 301(1):7-14. PubMed ID: 11907151
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetics and antiepileptic drugs.
Spear BB
Epilepsia; 2001; 42 Suppl 5():31-4. PubMed ID: 11887965
[TBL] [Abstract][Full Text] [Related]
24. Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment.
Grover S; Gourie-Devi M; Baghel R; Sharma S; Bala K; Gupta M; Narayanasamy K; Varma B; Gupta M; Kaur K; Talwar P; Kaur H; Giddaluru S; Sharma A; Brahmachari SK; Indian Genome Variation Consortium ; Kukreti R
Pharmacogenomics; 2010 Jul; 11(7):927-41. PubMed ID: 20602612
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
Bruhn O; Cascorbi I
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
[TBL] [Abstract][Full Text] [Related]
26. Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.
Potschka H
Pharmacogenomics; 2010 Oct; 11(10):1427-38. PubMed ID: 21047204
[TBL] [Abstract][Full Text] [Related]
27. [Drug resistance in epilepsy].
Czuczwar P; Kaczmarczyk K; Wierzchowska-Cioch E; Łuszczki JJ; Czuczwar SJ
Przegl Lek; 2009; 66(11):963-6. PubMed ID: 20297639
[TBL] [Abstract][Full Text] [Related]
28. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy.
Sánchez MB; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolás JM; Adín J; Armijo JA
Seizure; 2010 Mar; 19(2):93-101. PubMed ID: 20064729
[TBL] [Abstract][Full Text] [Related]
29. Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy.
Kim DW; Lee SK; Chu K; Jang IJ; Yu KS; Cho JY; Kim SJ
Epilepsy Res; 2009 Mar; 84(1):86-90. PubMed ID: 19167193
[TBL] [Abstract][Full Text] [Related]
30. ABC transporters in drug-refractory epilepsy: limited clinical significance of pharmacogenetics?
Cascorbi I
Clin Pharmacol Ther; 2010 Jan; 87(1):15-8. PubMed ID: 20019695
[No Abstract] [Full Text] [Related]
31. Polymorphic variants of the multidrug resistance gene Mdr1a and response to antiepileptic drug treatment in the kindling model of epilepsy.
Baars C; Löscher W; Leeb T; Becker A; Potschka H
Eur J Pharmacol; 2006 Nov; 550(1-3):54-61. PubMed ID: 17045987
[TBL] [Abstract][Full Text] [Related]
32. ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population.
Zhou L; Cao Y; Long H; Long L; Xu L; Liu Z; Zhang Y; Xiao B
Pharmazie; 2015 Jun; 70(6):416-20. PubMed ID: 26189305
[TBL] [Abstract][Full Text] [Related]
33. Association between G2677T/A polymorphism in ABCB1 gene and the risk of drug resistance epilepsy: An updated systematic review and meta-analysis.
Krami AM; Ratib C; Charoute H; Rouba H; Roky R; Barakat A; Nahili H
Epilepsy Res; 2022 Sep; 185():106977. PubMed ID: 35853334
[TBL] [Abstract][Full Text] [Related]
34. Various pharmacogenetic aspects of antiepileptic drug therapy: a review.
Mann MW; Pons G
CNS Drugs; 2007; 21(2):143-64. PubMed ID: 17284096
[TBL] [Abstract][Full Text] [Related]
35. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
Rogawski MA
Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature).
Smolarz B; Makowska M; Romanowicz H
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769124
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms of drug resistance in epilepsy].
Lasoń W
Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420
[TBL] [Abstract][Full Text] [Related]
38. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
Lakhan R; Misra UK; Kalita J; Pradhan S; Gogtay NJ; Singh MK; Mittal B
Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of antiepileptic drugs in the era of pharmacogenomics: A focus on childhood.
Gogou M; Pavlou E
Eur J Paediatr Neurol; 2019 Sep; 23(5):674-684. PubMed ID: 31280948
[TBL] [Abstract][Full Text] [Related]
40. Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.
Grewal GK; Kukal S; Kanojia N; Saso L; Kukreti S; Kukreti R
Molecules; 2017 Feb; 22(3):. PubMed ID: 28264441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
